Cargando…

Overview of Cellular Immunotherapies within Transfusion Medicine for the Treatment of Malignant Diseases

Over the years, transfusion medicine has developed into a broad, multidisciplinary field that covers different clinical patient services such as apheresis technology and the development of stem cell transplantation. Recently, the discipline has found a niche in development and production of advanced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tešić, Nataša, Poženel, Primož, Švajger, Urban
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151282/ https://www.ncbi.nlm.nih.gov/pubmed/34066067 http://dx.doi.org/10.3390/ijms22105120

Ejemplares similares

Combined TLR-3/TLR-8 Signaling in the Presence of α-Type-1 Cytokines Represents a Novel and Potent Dendritic Cell Type-1, Anti-Cancer Maturation Protocol
por: Fevžer, Tadej, et al.
Publicado: (2022)

Induction of Tolerogenic Dendritic Cells by Endogenous Biomolecules: An Update
por: Švajger, Urban, et al.
Publicado: (2018)

Post-radiation xerostomia therapy with allogeneic mesenchymal stromal stem cells in patients with head and neck cancer: study protocol for phase I clinical trial
por: Strojan, Primoz, et al.
Publicado: (2023)

Synergistic Effects of Interferon-γ and Vitamin D(3) Signaling in Induction of ILT-3(high)PDL-1(high) Tolerogenic Dendritic Cells
por: Švajger, Urban, et al.
Publicado: (2019)

Mixed cultures of allogeneic dendritic cells are phenotypically and functionally stable – a potential for primary cell-based “off the shelf” product generation
por: Švajger, Urban, et al.
Publicado: (2021)

Overview of Cellular Immunotherapy for Patients with Glioblastoma
por: Vauleon, Elodie, et al.
Publicado: (2010)

Induction/Engineering, Detection, Selection, and Expansion of Clinical-Grade Human Antigen-Specific CD8(+) Cytotoxic T Cell Clones for Adoptive Immunotherapy
por: Jeras, Matjaž, et al.
Publicado: (2010)

The landscape overview of CD47-based immunotherapy for hematological malignancies
por: Yang, Hua, et al.
Publicado: (2023)

Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series
por: Večerić-Haler, Željka, et al.
Publicado: (2022)

Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy
por: Večerić-Haler, Željka, et al.
Publicado: (2021)

C-type lectin DC-SIGN: An adhesion, signalling and antigen-uptake molecule that guides dendritic cells in immunity
por: Švajger, Urban, et al.
Publicado: (2010)

Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
por: Xu, Zhengli, et al.
Publicado: (2021)

Cellular immunotherapy for refractory hematological malignancies
por: Reagan, John L, et al.
Publicado: (2013)

BLOOD TRANSFUSION: a Guide to the Practice of Transfusion within Hospitals
Publicado: (1960)

Transfusion medicine as of 2014
por: Lozano, Miguel, et al.
Publicado: (2014)

Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments
por: Brandi, Giovanni, et al.
Publicado: (2019)

Combining Radiotherapy and Immunotherapy in Definitive Treatment of Head and Neck Squamous Cell Carcinoma: Review of Current Clinical Trials
por: Plavc, Gaber, et al.
Publicado: (2020)

Transfusions for anemia in adult and pediatric patients with malignancies
por: Shah, Neil, et al.
Publicado: (2015)

Emerging infections in transfusion medicine
por: Fiebig, Eberhard W., et al.
Publicado: (2004)

Cellular immunotherapy as a beacon of hope for hematological malignancies
por: Lee, Hyun-Ju, et al.
Publicado: (2015)

Current Situation and Prospect of Adoptive Cellular Immunotherapy for Malignancies
por: Zhao, Dong, et al.
Publicado: (2023)

The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma
por: Banerji, Shantanu, et al.
Publicado: (2021)

Cellular Immunotherapy and the Lung
por: Daly, Sorcha, et al.
Publicado: (2021)

Cellular immunotherapy for medulloblastoma
por: Schakelaar, Michael Y, et al.
Publicado: (2022)

Red blood cell transfusions impact response rates to immunotherapy in patients with solid malignant tumors
por: Mispelbaum, Rebekka, et al.
Publicado: (2022)

Transfusion Medicine
por: Tucci, Marisa, et al.
Publicado: (2014)

Transfusion Medicine
por: Wardrop, K. Jane
Publicado: (2008)

Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
por: Wang, Ji-nuo, et al.
Publicado: (2022)

Design, synthesis and activity evaluation of mannose-based DC-SIGN antagonists
por: Obermajer, Nataša, et al.
Publicado: (2010)

Pathogen Inactivation of Cellular Blood Products—An Additional Safety Layer in Transfusion Medicine
por: Seltsam, Axel
Publicado: (2017)

Immunotherapy in genitourinary malignancies
por: Mehta, Kathan, et al.
Publicado: (2017)

Cellular immunotherapies for cancer
por: Hayes, Conall
Publicado: (2020)

Contemporary issues in transfusion medicine informatics
por: Sharma, Gaurav, et al.
Publicado: (2011)

Transfusion Medicine and Molecular Genetic Methods
por: Saleh, Rozieyati Mohamed, et al.
Publicado: (2018)

Trypanosoma cruzi infection in transfusion medicine
por: Gómez, Lina Andrea, et al.
Publicado: (2019)

Regenerative Medicine-Based Treatment for Vitiligo: An Overview
por: Bellei, Barbara, et al.
Publicado: (2022)

Cellular Immunotherapy of Canine Cancer
por: Addissie, Selamawit, et al.
Publicado: (2018)

Cellular immunotherapy in multiple myeloma
por: Vo, Manh-Cuong, et al.
Publicado: (2019)

The Gene Manipulation and Cellular Immunotherapy Combination in the Treatment of Cancer
por: Khatami, Fatemeh, et al.
Publicado: (2022)

Familial Malignant Melanoma - Overview
por: Dębniak, Tadeusz
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_29e6ng0n7ogfrnlfv8kp40ugrq